Quantum Cyber plans a $250 million equity raise via ordinary shares, preferred shares, warrants, subscription rights and units to fund daily operations. The company also announced it will take over drone manufacturing in-house following its shift from pharmaceuticals to autonomous defense production.
In an S-3 filing, Quantum Cyber disclosed its intention to raise up to $250 million by offering ordinary shares, preferred shares, warrants, subscription rights and units in varying combinations and prices. The proceeds will support daily operations and help fund its expanding defense production initiatives.
The company recently terminated its manufacturing partner agreement with BP United to assume full responsibility for drone production, marking its strategic pivot from pharmaceutical licensing to a vertically integrated autonomous defense manufacturer. This U-turn aligns with its goal to control production efficiency and capture higher margins.
Quantum Cyber shares tumbled nearly 8% on the capital raise announcement, reversing a two-day gain and reflecting investor concerns over dilution. The stock has more than doubled year-to-date and risen 17% over the past year, highlighting elevated volatility amid major strategic changes.
